HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


McNeil Motrin Migraine Pain, Aflexa Supplement National Ads Breaking Soon

This article was originally published in The Tan Sheet

Executive Summary

McNeil Consumer Healthcare's Motrin Migraine Pain is reaching food, drug and mass store shelves now; the product began shipping nationwide April 5.

You may also be interested in...

Perrigo Indication-Specific Analgesics Slated For Mid-2001 Launch

Perrigo plans to launch a Women's Menstrual Relief analgesic in April, comparable to McNeil Consumer Healthcare's Women's Tylenol, which debuted in October.

Flexagen Joint Care "From The Makers of Advil " Hitting Shelves Now

Flexagen, a glucosamine/chondroitin joint care supplement, will be backed by a national TV and print ad campaign breaking in July, Whitehall-Robins announced at the National Association of Chain Drug Stores Marketplace in New Orleans June 25-28.

Advil Migraine Liqui-Gels Join Growing Category, Stress Distinctiveness

Upcoming marketing efforts accompanying the introduction of Whitehall-Robins' Advil Migraine Liqui-Gels likely will attempt to differentiate the product from its migraine-specific competitors by emphasizing the analgesic's speedy delivery form.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts